Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NUBP1 is a cytosolic iron-sulfur (Fe-S) cluster assembly factor that forms a heterotetrameric complex with NUBP2, functioning as a scaffold for the de novo assembly and transfer of Fe-S clusters to target apoproteins. It is a member of the Mrp/NBP35 family of ATP-binding proteins and is essential for the maturation of extramitochondrial Fe-S proteins. NUBP1 is implicated in pathways related to mitochondrial iron-sulfur cluster biogenesis and metabolic processes involving Fe-S proteins. Additionally, it plays a role in regulating centrosome duplication and cilium structure, though it is not currently considered a direct therapeutic target. Defects in NUBP1 function are associated with rare genetic diseases and broader cellular dysfunction due to impaired Fe-S protein maturation[2][4][6][7].
null
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cytosolic iron-sulfur cluster assembly factor NUBP1 (NUBP1).